In 2016 the term “unicorn”—a privately held company worth more than $1 billion—was already part of the tech lexicon. But applying that label to a European digital health company remains aspirational. In the United States, the Patient Protection and Affordable Care Act (PPACA) and broader reforms in the early 2010s created fertile ground for digital health startups: millions of newly …